Rankings
▼
Calendar
RIGL Q4 2016 Earnings — Rigel Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RIGL
Rigel Pharmaceuticals, Inc.
$517M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
-$9M
-287.8% margin
Operating Income
-$16M
-526.2% margin
Net Income
-$16M
-519.7% margin
EPS (Diluted)
$-1.58
QoQ Revenue Growth
-20.2%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$78M
Total Liabilities
$23M
Stockholders' Equity
$55M
Cash & Equivalents
$18M
← FY 2016
All Quarters
Q1 2017 →
